Effects of Liraglutide on left ventricular (LV) morphology, function and energy metabolism in patients with type 2 diabetes and heart failure : an in vivo cardiac Magnetic Resonance Imaging and 31P Spectroscopy study. Effetti della Liraglutide sul metabolismo energetico, morfologia e funzione del ventricolo sinistro (VS) nei pazienti con diabete di tipo 2 e insufficienza cardiaca: uno studio in vivo con Risonanza Magnetica cardiaca e spettroscopia del 31P.

Trial Profile

Effects of Liraglutide on left ventricular (LV) morphology, function and energy metabolism in patients with type 2 diabetes and heart failure : an in vivo cardiac Magnetic Resonance Imaging and 31P Spectroscopy study. Effetti della Liraglutide sul metabolismo energetico, morfologia e funzione del ventricolo sinistro (VS) nei pazienti con diabete di tipo 2 e insufficienza cardiaca: uno studio in vivo con Risonanza Magnetica cardiaca e spettroscopia del 31P.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Glimepiride (Primary) ; Liraglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms CARDIODIAB
  • Most Recent Events

    • 26 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top